|
|
| G
|
Abat
|
4-aminobutyrate aminotransferase
|
increases response to substance
|
ISO
|
ABAT mRNA results in increased susceptibility to Pentylenetetrazole
|
CTD |
PMID:10850552 |
|
NCBI chr10:7,503,351...7,599,474
Ensembl chr10:7,492,022...7,599,474
|
|
| G
|
Ache
|
acetylcholinesterase
|
increases activity multiple interactions
|
EXP
|
Pentylenetetrazole results in increased activity of ACHE protein Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of ACHE protein]
|
CTD |
PMID:35833322 |
|
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:25,043,461...25,050,410
|
|
| G
|
Adora2a
|
adenosine A2a receptor
|
affects response to substance
|
ISO
|
ADORA2A protein affects the susceptibility to Pentylenetetrazole
|
CTD |
PMID:19488739 |
|
NCBI chr20:13,315,270...13,332,802
Ensembl chr20:13,315,270...13,332,802
|
|
| G
|
Ager
|
advanced glycosylation end product-specific receptor
|
increases expression multiple interactions
|
EXP
|
Pentylenetetrazole results in increased expression of AGER protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of AGER protein]
|
CTD |
PMID:32653415 |
|
NCBI chr20:4,152,758...4,155,956
Ensembl chr20:4,151,965...4,155,685
|
|
| G
|
Akt1
|
AKT serine/threonine kinase 1
|
increases expression multiple interactions
|
EXP
|
Pentylenetetrazole results in increased expression of AKT1 mRNA Topiramate inhibits the reaction [Pentylenetetrazole results in increased expression of AKT1 mRNA]
|
CTD |
PMID:34266355 |
|
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
|
|
| G
|
Alad
|
aminolevulinate dehydratase
|
multiple interactions decreases activity
|
ISO
|
carvacryl acetate inhibits the reaction [Pentylenetetrazole results in decreased activity of ALAD protein]
|
CTD |
PMID:25490531 |
|
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:80,977,562...80,988,041
|
|
| G
|
App
|
amyloid beta precursor protein
|
multiple interactions increases expression
|
EXP
|
Dizocilpine Maleate inhibits the reaction [Pentylenetetrazole results in increased expression of APP mRNA]; Pentobarbital inhibits the reaction [Pentylenetetrazole results in increased expression of APP mRNA]; Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of APP protein] Pentylenetetrazole results in increased expression of APP mRNA; Pentylenetetrazole results in increased expression of APP protein
|
CTD |
PMID:9720974 PMID:32653415 |
|
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:37,506,408...37,722,971
|
|
| G
|
Bace1
|
beta-secretase 1
|
multiple interactions increases expression
|
EXP
|
Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of BACE1 protein]
|
CTD |
PMID:32653415 |
|
NCBI chr 8:55,038,842...55,061,138
Ensembl chr 8:55,038,823...55,064,918
|
|
| G
|
Bdnf
|
brain-derived neurotrophic factor
|
increases expression multiple interactions decreases expression
|
EXP ISO
|
Pentylenetetrazole results in increased expression of BDNF mRNA; Pentylenetetrazole results in increased expression of BDNF protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of BDNF protein] daidzin inhibits the reaction [Pentylenetetrazole results in decreased expression of BDNF protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in decreased expression of BDNF protein]
|
CTD |
PMID:11279263 PMID:32450180 PMID:32653415 |
|
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:116,619,633...116,670,657
|
|
| G
|
Casp3
|
caspase 3
|
multiple interactions increases expression
|
EXP
|
Thiamine inhibits the reaction [Pentylenetetrazole results in increased expression of CASP3 protein]; Topiramate inhibits the reaction [Pentylenetetrazole results in increased expression of CASP3 mRNA] Pentylenetetrazole results in increased expression of CASP3 mRNA; Pentylenetetrazole results in increased expression of CASP3 protein
|
CTD |
PMID:33771525 PMID:34266355 |
|
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
|
|
| G
|
Cat
|
catalase
|
decreases expression multiple interactions decreases activity increases activity
|
EXP ISO
|
Pentylenetetrazole results in decreased expression of CAT protein daidzin inhibits the reaction [Pentylenetetrazole results in decreased activity of CAT protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in decreased activity of CAT protein] Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of CAT protein]
|
CTD |
PMID:16122723 PMID:32450180 PMID:35833322 |
|
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:110,297,342...110,329,526
|
|
| G
|
Cnr1
|
cannabinoid receptor 1
|
increases response to substance
|
ISO
|
CNR1 gene mutant form results in increased susceptibility to Pentylenetetrazole
|
CTD |
PMID:26460022 |
|
NCBI chr 5:53,204,867...53,230,396
Ensembl chr 5:53,204,260...53,239,252
|
|
| G
|
Drd1
|
dopamine receptor D1
|
multiple interactions
|
ISO
|
[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole; Raclopride inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]; SCH 23390 inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]
|
CTD |
PMID:8103921 |
|
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166
|
|
| G
|
Drd2
|
dopamine receptor D2
|
multiple interactions
|
ISO
|
[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole; Raclopride inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]; SCH 23390 inhibits the reaction [[[Apomorphine binds to and results in increased activity of DRD1 protein] co-treated with [Apomorphine binds to and results in increased activity of DRD2 protein]] results in decreased susceptibility to Pentylenetetrazole]
|
CTD |
PMID:8103921 |
|
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
|
|
| G
|
Fos
|
Fos proto-oncogene, AP-1 transcription factor subunit
|
multiple interactions increases expression
|
ISO EXP
|
Diazepam inhibits the reaction [Pentylenetetrazole results in increased expression of FOS mRNA]; Pentobarbital inhibits the reaction [Pentylenetetrazole results in increased expression of FOS mRNA] Pentylenetetrazole results in increased expression of FOS mRNA; Pentylenetetrazole results in increased expression of FOS protein delta-hexachlorocyclohexane inhibits the reaction [Pentylenetetrazole results in increased expression of FOS mRNA]; delta-hexachlorocyclohexane inhibits the reaction [Pentylenetetrazole results in increased expression of FOS protein]; Dizocilpine Maleate inhibits the reaction [Pentylenetetrazole results in increased expression of FOS protein]; Nifedipine inhibits the reaction [Pentylenetetrazole results in increased expression of FOS protein]
|
CTD |
PMID:1380685 PMID:3037702 PMID:7534335 PMID:7887109 PMID:8809800 PMID:11421588 PMID:15857624 More...
|
|
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:110,852,190...110,855,598
|
|
| G
|
Gabra1
|
gamma-aminobutyric acid type A receptor subunit alpha 1
|
multiple interactions
|
ISO
|
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
|
CTD |
PMID:14637376 |
|
NCBI chr10:27,096,731...27,152,563
Ensembl chr10:27,096,740...27,152,442
|
|
| G
|
Gabra2
|
gamma-aminobutyric acid type A receptor subunit alpha 2
|
multiple interactions
|
ISO
|
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]]
|
CTD |
PMID:14637376 |
|
NCBI chr14:37,451,218...37,587,458
Ensembl chr14:37,450,683...37,587,457
|
|
| G
|
Gabrb2
|
gamma-aminobutyric acid type A receptor subunit beta 2
|
multiple interactions
|
ISO
|
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
|
CTD |
PMID:14637376 |
|
NCBI chr10:27,438,127...27,657,680
Ensembl chr10:27,438,238...27,655,171
|
|
| G
|
Gabrg2
|
gamma-aminobutyric acid type A receptor subunit gamma 2
|
multiple interactions
|
ISO
|
Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane binds to [GABRA2 protein binds to GABRB2 protein binds to GABRG2 protein]]; Pentylenetetrazole inhibits the reaction [tert-butylbicyclophosphorothionate binds to [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
|
CTD |
PMID:14637376 |
|
NCBI chr10:26,876,926...26,965,523
Ensembl chr10:26,876,926...26,965,523
|
|
| G
|
Gad2
|
glutamate decarboxylase 2
|
increases response to substance
|
ISO
|
GAD2 gene mutant form results in increased susceptibility to Pentylenetetrazole
|
CTD |
PMID:8954991 |
|
NCBI chr17:89,671,718...89,734,246
Ensembl chr17:89,671,716...89,941,089
|
|
| G
|
Gcg
|
glucagon
|
decreases expression multiple interactions
|
EXP
|
Pentylenetetrazole results in decreased expression of GCG protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in decreased expression of GCG protein]
|
CTD |
PMID:32653415 |
|
NCBI chr 3:67,522,489...67,531,533
Ensembl chr 3:67,522,489...67,531,533
|
|
| G
|
Gsk3b
|
glycogen synthase kinase 3 beta
|
decreases phosphorylation multiple interactions
|
EXP
|
Pentylenetetrazole results in decreased phosphorylation of GSK3B protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in decreased phosphorylation of GSK3B protein]
|
CTD |
PMID:32653415 |
|
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:76,009,507...76,153,249
|
|
| G
|
Gsr
|
glutathione-disulfide reductase
|
multiple interactions increases activity
|
EXP
|
Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of GSR protein]
|
CTD |
PMID:35833322 |
|
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:65,185,574...65,228,394
|
|
| G
|
Hmox1
|
heme oxygenase 1
|
decreases expression multiple interactions
|
ISO
|
Pentylenetetrazole results in decreased expression of HMOX1 protein daidzin inhibits the reaction [Pentylenetetrazole results in decreased expression of HMOX1 protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in decreased expression of HMOX1 protein]
|
CTD |
PMID:32450180 |
|
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,472,884...13,479,818
|
|
| G
|
Igf1
|
insulin-like growth factor 1
|
increases expression multiple interactions
|
EXP
|
Pentylenetetrazole results in increased expression of IGF1 protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of IGF1 protein]
|
CTD |
PMID:32653415 |
|
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:24,130,137...24,246,764
|
|
| G
|
Kcnq2
|
potassium voltage-gated channel subfamily Q member 2
|
increases response to substance
|
ISO
|
KCNQ2 protein mutant form results in increased susceptibility to Pentylenetetrazole
|
CTD |
PMID:26910900 |
|
NCBI chr 3:188,572,345...188,631,391
Ensembl chr 3:188,572,926...188,631,302
|
|
| G
|
Mapt
|
microtubule-associated protein tau
|
multiple interactions increases phosphorylation
|
EXP
|
Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased phosphorylation of MAPT protein]
|
CTD |
PMID:32653415 |
|
NCBI chr10:89,638,618...89,736,108
Ensembl chr10:89,638,599...89,736,108
|
|
| G
|
Mmp9
|
matrix metallopeptidase 9
|
increases expression multiple interactions
|
EXP
|
Pentylenetetrazole results in increased expression of MMP9 protein Sitagliptin Phosphate inhibits the reaction [Pentylenetetrazole results in increased expression of MMP9 protein]
|
CTD |
PMID:32653415 |
|
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:174,084,123...174,111,442
|
|
| G
|
Mpdz
|
multiple PDZ domain crumbs cell polarity complex component
|
affects response to substance
|
ISO
|
MPDZ protein affects the susceptibility to Pentylenetetrazole
|
CTD |
PMID:14960011 |
|
NCBI chr 5:100,812,121...100,966,566
Ensembl chr 5:100,812,124...100,966,504
|
|
| G
|
Mpo
|
myeloperoxidase
|
multiple interactions increases activity
|
EXP
|
Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of MPO protein]
|
CTD |
PMID:35833322 |
|
NCBI chr10:73,092,124...73,102,057
Ensembl chr10:73,092,400...73,102,056
|
|
| G
|
Nr4a1
|
nuclear receptor subfamily 4, group A, member 1
|
increases expression multiple interactions
|
ISO
|
Pentylenetetrazole results in increased expression of NR4A1 mRNA Dexamethasone inhibits the reaction [Pentylenetetrazole results in increased expression of NR4A1 mRNA]
|
CTD |
PMID:8164692 |
|
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:134,247,192...134,268,041
|
|
| G
|
Nr4a2
|
nuclear receptor subfamily 4, group A, member 2
|
increases expression
|
ISO
|
Pentylenetetrazole results in increased expression of NR4A2 mRNA
|
CTD |
PMID:8164692 |
|
NCBI chr 3:62,098,739...62,115,926
Ensembl chr 3:62,098,743...62,106,769
|
|
| G
|
Nrp2
|
neuropilin 2
|
affects response to substance
|
ISO
|
NRP2 protein affects the susceptibility to Pentylenetetrazole
|
CTD |
PMID:18657176 |
|
NCBI chr 9:71,616,602...71,731,869
Ensembl chr 9:71,616,657...71,731,871
|
|
| G
|
Nrxn1
|
neurexin 1
|
multiple interactions
|
ISO
|
NRXN1 protein affects the reaction [NLG-1 results in decreased susceptibility to Pentylenetetrazole]
|
CTD |
PMID:23638761 |
|
NCBI chr 6:8,931,360...10,077,381
Ensembl chr 6:8,935,523...10,077,374
|
|
| G
|
Oprk1
|
opioid receptor, kappa 1
|
decreases response to substance
|
ISO
|
OPRK1 gene results in decreased susceptibility to Pentylenetetrazole
|
CTD |
PMID:17126860 |
|
NCBI chr 5:18,657,866...18,675,671
Ensembl chr 5:18,657,871...18,675,671
|
|
| G
|
Pam
|
peptidylglycine alpha-amidating monooxygenase
|
affects response to substance
|
ISO
|
PAM protein affects the susceptibility to Pentylenetetrazole
|
CTD |
PMID:19815072 |
|
NCBI chr 9:105,445,812...105,719,287
Ensembl chr 9:105,445,929...105,719,285
|
|
| G
|
Pdyn
|
prodynorphin
|
increases cleavage decreases expression
|
EXP
|
Pentylenetetrazole results in increased cleavage of PDYN protein Pentylenetetrazole results in decreased expression of PDYN mRNA
|
CTD |
PMID:1465197 |
|
NCBI chr 3:137,354,161...137,366,503
Ensembl chr 3:137,354,161...137,366,503
|
|
| G
|
Rps6
|
ribosomal protein S6
|
increases expression multiple interactions
|
EXP
|
Pentylenetetrazole results in increased expression of RPS6 mRNA Topiramate inhibits the reaction [Pentylenetetrazole results in increased expression of RPS6 mRNA]
|
CTD |
PMID:34266355 |
|
NCBI chr 5:106,417,680...106,420,540
Ensembl chr 5:106,417,680...106,420,566
|
|
| G
|
Slc6a2
|
solute carrier family 6 member 2
|
increases response to substance
|
ISO
|
SLC6A2 protein results in increased susceptibility to Pentylenetetrazole
|
CTD |
PMID:15911120 |
|
NCBI chr19:30,183,289...30,228,292
Ensembl chr19:30,183,383...30,223,348
|
|
| G
|
Sod1
|
superoxide dismutase 1
|
decreases expression
|
EXP
|
Pentylenetetrazole results in decreased expression of SOD1 protein
|
CTD |
PMID:16122723 |
|
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:42,942,678...42,948,399
|
|
| G
|
Vegfa
|
vascular endothelial growth factor A
|
increases expression multiple interactions
|
ISO
|
Pentylenetetrazole results in increased expression of VEGFA protein daidzin inhibits the reaction [Pentylenetetrazole results in increased expression of VEGFA protein]; Diazepam inhibits the reaction [Pentylenetetrazole results in increased expression of VEGFA protein]
|
CTD |
PMID:32450180 |
|
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:22,439,392...22,468,194
|
|
| G
|
Xdh
|
xanthine dehydrogenase
|
multiple interactions increases activity
|
EXP
|
Vitamin U inhibits the reaction [Pentylenetetrazole results in increased activity of XDH protein]
|
CTD |
PMID:35833322 |
|
NCBI chr 6:27,282,319...27,344,022
Ensembl chr 6:27,282,057...27,344,350
|
|